Analysis of the novel factor X gene mutation Glus5 I Lys in two families with factor X-Riyadh anomaly

Thrombosis and Haemostasis

Volumn 97, Issue 4, 2007, Pages 542-545

  Al Hilali, Akram ^a   Wulff, Karin ^b   Abdel Razeq, Hikmat ^c   Saud, Khalida Abu ^a   Al Gaili, Fateh ^a   Herrmann, Falko H ^b  

^a KING FAHD ARMED FORCES HOSPITAL   (Saudi Arabia)

^b UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^c Section of Hematology and Medical Oncology   (Jordan)

Author keywords

Exon 4; Factor X Riyadh; Mutation; Partial thromboplastin time; Prothrombin time

Indexed keywords

ASPARAGINE; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7A; EPIDERMAL GROWTH FACTOR; GLUTAMIC ACID; LYSINE; THROMBOPLASTIN;

ADOLESCENT; ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING FACTOR 10 DEFICIENCY; BLOOD CLOTTING FACTOR 10 RIYADH ANOMALY; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; FEMALE; HUMAN; HYDROGEN BOND; MALE; MISSENSE MUTATION; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTHROMBIN TIME; SEQUENCE ANALYSIS;

ADOLESCENT; ADULT; AGED; CHILD; DNA MUTATIONAL ANALYSIS; EXONS; FACTOR X; FACTOR X DEFICIENCY; FEMALE; GENOTYPE; GLUTAMIC ACID; HUMANS; LYSINE; MALE; MIDDLE AGED; MUTATION, MISSENSE; PARTIAL THROMBOPLASTIN TIME; PEDIGREE; PHENOTYPE; PROTHROMBIN TIME; SAUDI ARABIA;

EID: 34247105003     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH06-09-0532     Document Type: Article

References (13)

1. William WJ, Beutler E, Erslev AJ, et al. Hematology. 2nd Ed. McGraw Hill: New York, 1977: 1418-1419.
2. + Riyadh). Ann Saudi Med 1989; 9: 48-51.
3. Lewis SM, Bain B, Bates I, et al. Dacie and Lewis: Practical Haematology. London, Churchill Livingstone; 2001.
4. Herrmann FH, Navarette M, Salazar-Sanchez L, et al. Homozygous factor X mutations Gly380Arg and Tyr163delAT are associated with perinatal intracranial hemorrhage. J Pediat 2005; 146: 128-130.
5. Denson KW, Lurie A, de Cataldo F, et al. The factor X defect. Recognition of abnormal forms of factor X. Br J Haematol 1970; 18: 317-327.
6. Hougie C et al. Stuart clotting defect. J Clin Invest 1957; 36: 485-492.
7. Fair DS, Plow EF, Edington TS. Combined functional and immunochemical analysis of normal and abnormal human factor X. J Clin Invest 1979; 64: 884-894.
8. Hoffbrand AV, Lewis SM, Tuddenham EG. Postgraduate Haematology. Oxford; Butterworth Heinemann, 1999.
9. Girolami A, Vicariota M, Ruzza G, et al. Factor X Padua: a "new" congenital factor X abnormality with a defect only in the extrinsic system. Acta Haematol 1985; 73: 31-36.
10. Girolami A, Vianello F Cabrio L, et al. A new mutation (Arg251Trp) in the Ca+ binding site of factor X protease domain appears to be responsible for the defect in the extrinsic pathway activation of factor X Padua. Clin Appl Thromb Hemost 2004; 10: 5-8.
11. Herrmann FH, Auserwald G, Ruiz-Saez A, et al. and the Greisfswald Factor X Deficiency Study Group. Factor X deficiency: clinical manifestation of 102 subjects from Europe and Latin America with mutations in the factor X gene. Haemophilia 2006; 12: 479-489.
12. Peyvandi E Menegatti M, Santagostino E, et al. Gene mutations and three-dimensional structural analysis in 13 families with severe factor X deficiency. Br J Haematol 2002; 117: 685-692.
13. Venkateswarlu D, Duke RE, Perera L, et al. An all-atom solution-equilibrated model for human extrinsic blood coagulation complex (sTF-VII-Xa): A protein-protein decking and molecular dynamic refinement study. J Thromb Haemost 2003; 1: 2577-2588.